Cassie Saitow

Cassie Saitow is Associate Director of Investor Relations at Blueprint Medicines, and also leads ESG strategy and reporting. With a PhD in Cell and Molecular Biology, she brings a science lens to IR strategy. Prior to her current role, she held positions in Investor Relations at PTC Therapeutics, and as an Associate Professor at Simmons University.